Dec 15, 2017 Bloomberg

A ‘Better Botox’ May Target Millennials, Men and Hesitant Women

LIKE ({{state.likes}})
BOOKMARK
A ‘Better Botox’ May Target Millennials, Men and Hesitant Women - ZALEA Article Banner

Revance Therapeutics Inc’s lead asset is a new form of botulinum toxin, akin to the best-selling wrinkle eraser, Botox, but with a key difference, durability, according to Chief Executive Officer Daniel Browne. Recent results in a late-stage study may back up his claim.

Read the rest of the article at Bloomberg

Join the Discussion

zaleareview
RELATED TAGS
Food and Drug Administration
VIEW {{!state.tags ?'ALL' : 'LESS'}}   >
GLOSSARY
Chemical Peel
Dermabrasion
Laser Resurfacing
Sunburn
Wrinkles
VIEW {{!state.glossary ?'ALL' : 'LESS'}}   >

Register for FREE

Sign-up here to ACCESS Exclusive Benefits
X

You must sign up with ZALEA to read more content.

Free Sign Up